Please use this identifier to cite or link to this item: http://ithesis-ir.su.ac.th/dspace/handle/123456789/4482
Full metadata record
DC FieldValueLanguage
dc.contributorYin Yin MYATen
dc.contributorYin Yin Myatth
dc.contributor.advisorPrasopchai Patrojanasophonen
dc.contributor.advisorประสพชัย พัฒน์โรจนโสภณth
dc.contributor.otherSilpakorn Universityen
dc.date.accessioned2023-08-11T02:30:39Z-
dc.date.available2023-08-11T02:30:39Z-
dc.date.created2023
dc.date.issued4/7/2023
dc.identifier.urihttp://ithesis-ir.su.ac.th/dspace/handle/123456789/4482-
dc.description.abstractThis study aimed to develop three types of nanocarriers for targeted delivery of chemotherapeutic drugs to colorectal and breast cancers: Polyethylene glycol diacrylate/polyacrylic acid nanoparticles (PEGDA/AA NPs), trastuzumab (Tras)-decorated liposomes (Tras-Lip), and Tras-decorated maleimide-conjugated chitosan/cysteine-conjugated alginate nanoparticles (Tras-CHI-Mal/Alg-Cys NPs). Doxorubicin (Dox) and curcumin were selected as model compounds.  PEGDA/AA NPs were prepared by surfactant-free emulsion polymerization using V50 azo initiator and bisacrylamide crosslinker. Tras-Lip formulations were prepared by thin-film hydration method followed by coating with iodoacetamide grafted chitosan (CHI-IA) and conjugated with Tras. Tras-CHI-Mal/Alg-Cys NPs were prepared by ionic gelation and click reaction between the polymers and followed by conjugation with Tras by the thiol-maleimide reaction. The structural characterization was performed using proton nuclear magnetic resonance (1H-NMR), attenuated total reflection Fourier transform infrared (ATR-FTIR) and inductively coupled plasma mass spectrometers (ICP-MS). Their physicochemical properties, morphology, drug content/release, antibody content, and cytotoxicity on normal and cancer cells were investigated. The cellular uptake and apoptosis mechanism of the nanocarriers on colorectal and HER2-positive breast cancer cells were also determined.  All nanocarriers were successfully developed with desirable sizes, good polydispersity index, and presented a spherical shape. The zeta potential of PEGDA/AA NPs and CHI-Mal/Alg-Cys NPs were negative charges, while that of Tras-Lip was positive. Dox was encapsulated in the nanocarriers with a % loading efficiency (%LE) of 45.8 ± 0.23 % in PEGDA/AA NPs and 84.6 ± 5.2 % in Tras-CHI-IA coated liposome. Dox was released completely from PEGDA/AA NPs and 78.0 ± 1.8 % from Tras-CHI-IA coated liposome within 24 h at tumor pH. Curcumin was incorporated with a high %LE of 74 ± 3.2% in CHI-Mal/Alg-Cys NPs and released completely within 7 days in tumor pH. The nanocarriers showed potent cytotoxic effects with relatively low IC50 values against HT-29 and SK-BR-3 cells while being non-toxic to Caco-2 and HGF cells . Dox-PEGDA/AA NPs were able to be accumulated passively inside colorectal cancer cells and induce apoptosis, while Tras-CHI-IA coated liposomes and curcumin-CHI-Mal/Alg-Cys NPs demonstrated greater cell toxicity towards breast cancer cells via ligand-receptor mediated endocytosis. Our findings suggest that these nanocarriers could be promising carriers for delivering therapeutic anti-cancer drugs by both passive and active targeting strategies.en
dc.description.abstract-th
dc.language.isoen
dc.publisherSilpakorn University
dc.rightsSilpakorn University
dc.subjectColorectal canceren
dc.subjectBreast canceren
dc.subjectNanocarriersen
dc.subjectTargeted Drug Deliveryen
dc.subjectPolyethylene glycol diacrylateen
dc.subjectAcrylic aciden
dc.subjectChitosanen
dc.subjectIodoacetamideen
dc.subjectAlginateen
dc.subjectMaleimideen
dc.subjectCysteineen
dc.subject.classificationPharmacologyen
dc.subject.classificationManufacturingen
dc.titleDevelopment of nano-based drug-delivering carriers for colorectal and breast cancer targetingen
dc.title-th
dc.typeThesisen
dc.typeวิทยานิพนธ์th
dc.contributor.coadvisorPrasopchai Patrojanasophonen
dc.contributor.coadvisorประสพชัย พัฒน์โรจนโสภณth
dc.contributor.emailadvisorpatrojanasophon_p@su.ac.th
dc.contributor.emailcoadvisorpatrojanasophon_p@su.ac.th
dc.description.degreenameDoctor of Philosophy (Ph.D.)en
dc.description.degreenameปรัชญาดุษฎีบัณฑิต (ปร.ด.)th
dc.description.degreelevelDoctoral Degreeen
dc.description.degreelevelปริญญาเอกth
dc.description.degreedisciplinePHARMACEUTICAL TECHNOLOGYen
dc.description.degreedisciplineเทคโนโลยีเภสัชกรรมth
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
620830007.pdf6.59 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.